United Therapeutics Corporation (UTHR)
Total asset turnover
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 2,877,400 | 2,756,200 | 2,616,700 | 2,498,300 | 2,327,500 | 2,204,300 | 2,110,900 | 1,981,300 | 1,936,300 | 1,860,000 | 1,788,700 | 1,768,300 | 1,685,500 | 1,655,200 | 1,590,600 | 1,506,100 | 1,483,300 | 1,409,500 | 1,430,900 | 1,442,500 |
Total assets | US$ in thousands | 7,364,000 | 7,123,100 | 6,723,200 | 6,495,200 | 7,167,000 | 7,023,600 | 6,681,300 | 6,346,000 | 6,044,500 | 5,781,600 | 5,543,300 | 5,359,800 | 5,169,100 | 5,048,900 | 4,844,900 | 4,641,000 | 4,615,000 | 4,411,200 | 4,219,400 | 4,025,900 |
Total asset turnover | 0.39 | 0.39 | 0.39 | 0.38 | 0.32 | 0.31 | 0.32 | 0.31 | 0.32 | 0.32 | 0.32 | 0.33 | 0.33 | 0.33 | 0.33 | 0.32 | 0.32 | 0.32 | 0.34 | 0.36 |
December 31, 2024 calculation
Total asset turnover = Revenue (ttm) ÷ Total assets
= $2,877,400K ÷ $7,364,000K
= 0.39
United Therapeutics Corporation's total asset turnover has shown some fluctuations over the time period provided. The ratio has ranged from a low of 0.31 to a high of 0.39. Generally, a higher total asset turnover ratio indicates that the company is generating more sales for each dollar of assets it owns.
The decreasing trend in the total asset turnover ratio from 0.36 on March 31, 2020, to 0.32 on December 31, 2022, implies that the company's efficiency in utilizing its assets to generate revenue decreased during this period. However, there was a slight increase in the ratio to 0.32 by March 31, 2024, and a further improvement to 0.39 by December 31, 2024.
It is important to further investigate the factors influencing these fluctuations in total asset turnover to understand the company's operational efficiency and asset utilization. Additional analysis of United Therapeutics Corporation's financial performance and business operations would provide a more comprehensive insight into the significance of these changes in the total asset turnover ratio.
Peer comparison
Dec 31, 2024